Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (5): 741-743    DOI: 10.31083/j.ceog.2020.05.5373
Original Research Previous articles | Next articles
Seroprevalence of Dengue virus among pregnant mothers and their-newborn infants in the southwest of Saudi Arabia
Ali S. Alqahtani1, *()
1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, 1988, Kingdom of Saudi Arabia
Download:  PDF(159KB)  ( 106 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Dengue virus (DENV) is one of the most serious arthropod-borne viruses. This study was performed to investigate the prevalence of the virus in Najran, a city in the south west of Saudi Arabia. Four hundred and ten paired maternal and umbilical serum samples were obtained from mothers and their newborn infants. The samples were tested for the presence of IgG antibodies by ELISA. Anti-DENV IgG antibodies were detected in 31 maternal samples (7.6%), while all newborn samples were negative. All maternal seropositive samples were negative when tested by PCR. These results are further indication that DENV is endemic in Saudi Arabia and enhanced DENV surveillance is necessary.

Key words:  Dengue      ELISA      PCR      Serum      Saudi Arabia      Pregnancy      Newborn infants     
Submitted:  15 September 2019      Accepted:  07 November 2019      Published:  15 October 2020     
*Corresponding Author(s):  Ali S. Alqahtani     E-mail:  almezherali@gmail.com

Cite this article: 

Ali S. Alqahtani. Seroprevalence of Dengue virus among pregnant mothers and their-newborn infants in the southwest of Saudi Arabia. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 741-743.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.05.5373     OR     https://ceog.imrpress.com/EN/Y2020/V47/I5/741

Table 1  — Demographic and clinical characteristics of the mothers.
Variables Total N (%) DENV IgG positive
N (%)
Residency In Najran 342 (83.4) 29 (8.5)
Out of Najran 68 (16.6) 2 (2.9)
History of travel Yes 35 (8.5) 0 (0)
No 375 (91.5) 31 (8.3)
Temperature 37 407 (99.3) 31 (7.6)
> 38 ℃ 3 (0.7) 0 (0)
[1] Gubler D.J.: “The global emergence/resurgence of arboviral diseases as public health problems”. Arch. Med. Res., 2002, 33, 330-342.
doi: 10.1016/S0188-4409(02)00378-8
[2] Ferguson N.M., Donnelly C.A., Anderson R.M.: “Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys”. Philos. Trans. R. Soc. Lond. B Bio. Sci., 1999, 354, 757-768.
[3] Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al.: “The global distribution and burden of dengue”. Nature, 2013, 496, 504-507.
doi: 10.1038/nature12060
[4] Aziz A., Al-Shami S., Mahyoub J.A., Hatabbi M., Ahmad A., Rawi C.: “An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito”. Parasites & Vectors, 2014, 7, 258.
doi: 10.1186/1756-3305-7-258 pmid: 24890567
[5] Ashshi A.M.: “Serodetection of Dengue virus and its antibodies among blood donors in the western region of Saudi Arabia: a preliminary study”. Blood Transfus., 2015, 13, 135-138.
doi: 10.2450/2014.0134-14 pmid: 25369603
[6] Azhar E., Kao M., Niedrig M., Masri B., Godus A., Badierah R. et al.: “Virological diagnosis of dengue fever in Jeddah, Saudi Arabia: comparison between RT-PCR and virus isolation in cell culture”. Infect. Dis. Immun., 2010, 2, 24-29.
[7] Jamjoom G.A., Azhar E.I., Kao M.A., Radadi R.M.: “Seroepidemiology of asymptomatic Dengue virus infection in Jeddah, Saudi Arabia”. Virology(Auckl), 2016, 7, VRT. S34187.
[8] Alhaeli A., Bahkali S., Ali A., Househ M.S. El-Metwally A.A.: “The epidemiology of Dengue fever in Saudi Arabia: A systematic review”. J. Infect. Public Health, 2016, 9, 117-124.
doi: 10.1016/j.jiph.2015.05.006 pmid: 26106040
[9] Al-Azraqi T.A., El Mekki A.A. Mahfouz A.A.: “Seroprevalence of dengue virus infection in Aseer and Jizan regions, Southwestern Saudi Arabia”. Trans. R. Soc. Trop. Med. Hyg., 2013, 107, 368-371.
doi: 10.1093/trstmh/trt022 pmid: 23474472
[10] Al-Raddadi R., Alwafi O., Shabouni O., Akbar N., Alkhalawi M., Ibrahim A., et al.: “Seroprevalence of dengue fever and the associated sociodemographic, clinical, and environmental factors in Makkah, Madinah, Jeddah, and Jizan, Kingdom of Saudi Arabia”. Acta. Trop., 2019, 189, 54-64.
doi: 10.1016/j.actatropica.2018.09.009 pmid: 30244133
[11] Ashshi A.M., Alghamdi S., El-Shemi A.G., Almdani S., Refaat B., Mohamed A., et al.: “Seroprevalence of asymptomatic dengue virus infection and its antibodies among healthy/eligible saudi blood donors: Findings from Holy Makkah City”. Virol.: Research and Treatment, 2017, 8, 1178122X1769126.
[12] Gabor J.J., Schwarz N.G., Esen M., Kremsner P.G. Grobusch M.P.: “Dengue and chikungunya seroprevalence in Gabonese infants prior to major outbreaks in 2007 and 2010: A sero-epidemiological study”. Travel Med. Infect. Dis., 2016, 14, 26-31.
doi: 10.1016/j.tmaid.2016.01.005 pmid: 26869532
[13] Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J. Vorndam A.V.: “Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.”. J. Clin. Microbiol., 1992, 30, 545-551.
doi: 10.1128/JCM.30.3.545-551.1992 pmid: 1372617
[14] Kuno G., Gómez I. and Gubler D.J.: “An ELISA procedure for the diagnosis of dengue infections”. J. Virol. Methods, 1991, 33, 101-113.
doi: 10.1016/0166-0934(91)90011-n pmid: 1939502
[15] Innis B.L., Suntayakorn S., Nimmannitya S., Hoke C.H., Chongswasdi V., Puttisri P., et al.: “An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate”. Am. J. Trop. Med. Hyg., 1989, 40, 418-427.
doi: 10.4269/ajtmh.1989.40.418 pmid: 2540664
[16] Alcon S., Talarmin A., Debruyne M., Falconar A., Deubel V. Flamand M.: “Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein ns1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections”. J. Clin. Microbiol., 2002, 40, 376-381.
doi: 10.1128/jcm.40.02.376-381.2002 pmid: 11825945
[17] Young P.R., Hilditch P. A., Bletchly C., Halloran W.: “An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein ns1 in the sera of infected patients”. J. Clin. Microbiol., 2000, 38, 1053-1057.
doi: 10.1128/JCM.38.3.1053-1057.2000 pmid: 10698995
[18] Guzmán M.G. and Kourí G.: “Advances in dengue diagnosis.”. Clin. Diagn. Lab. Immunol., 1996, 3, 621-627.
pmid: 8914749
[19] Koraka P., Burghoorn-Maas C.P., Falconar A., Setiati T.E., Djamiatun K., Groen J., et al.: “Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections”. J. Clin. Microbiol., 2003, 41, 4154-4159.
doi: 10.1128/jcm.41.9.4154-4159.2003 pmid: 12958240
[20] Fritzell C., Rousset D., Adde A., Kazanji M., Van Kerkhove M.D., Flamand C.: “Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review”. Plos Negl. Trop. Dis., 2018, 12, e0006533.
doi: 10.1371/journal.pntd.0006533 pmid: 30011271
[21] Wilder-Smith A., Chen L.H., Massad E. Wilson M.E.: “Threat of dengue to blood safety in dengue-endemic countries”. Emerg. Infect. Dis., 2009, 15, 8-11.
doi: 10.3201/eid1501.071097 pmid: 19116042
[22] Ribas-Silva R.C. Eid A.A.: “Dengue antibodies in blood donors”. Rev. Bra. De Hematol. Hemoter., 2012, 34, 193-195.
[23] Mangwana S.: “Dengue viremia in blood donors in Northern India: Challenges of emerging dengue outbreaks to blood transfusion safety”. Asian J. Transfus. Sci., 2015, 9, 177.
doi: 10.4103/0973-6247.154253 pmid: 26420940
[1] Amanda M. Wang, Alan J. Lee, Shannon M. Clark. The effects of overweight and obesity on pregnancy-related morbidity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 999-1009.
[2] Leen Van den Eeden, Greet Leysens,Dominique Mannaerts, Yves Jacquemyn. Air pollution: cardiovascular and other negative effects on pregnancy: a narrative review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1010-1016.
[3] Xin Du, Qian Zou, Yu-Lan Liu. Transumbilical single-hole laparoscopic treatment of cesarean scar pregnancy by uterine artery pre-ligation: a report of 4 cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1044-1047.
[4] Marcelo Epsztein Kanczuk, Nicholas J Lightfoot, Alison Pighills, Antony Ji, Casey Steele, Daniel Bartlett. The time to perform spinal or general anaesthesia in COVID-19 positive parturients requiring emergency caesarean delivery: a prospective crossover simulation study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1099-1106.
[5] Noor Hazim Abdulkareem, Elham Hazeim Abdulkareem. SARS-CoV-2 detection in pregnant and non-pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1141-1145.
[6] Min Jung Kim, Hee-Sook Lim, Hae-Hyeog Lee, Tae-Hee Kim, Yongsoon Park. Dietary assessment, nutrition knowledge, and pregnancy outcome in high-risk pregnant Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1178-1185.
[7] Neha Sethi, Ann Gee Tan, Maherah Kamarudin, Sofiah Sulaiman. Successful delivery of a twin pregnancy with complete hydatidiform mole and coexistent live fetus: a case report and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1232-1247.
[8] Luca Roncati, Greta Gianotti, Elisa Ambrogi, Giovanna Attolini. COVID-19 in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 778-780.
[9] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[10] Yu Deng, Zhan-Hui Ou, Min-Na Yin, Pei-Ling Liang, Zhi-Heng Chen, Abraham Morse, Ling Sun. Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 835-841.
[11] Serdar Balci. The effect of ultraviolet index measurements on levels of vitamin D andinflammatory markers in pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 888-892.
[12] Anna M. Rubinshtein, Oleg V. Golyanovskiy. Obstetric outcomes in women of advanced maternal age after assisted reproduction[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 893-900.
[13] Qian Hu, Mohammed Sharooq Paramboor, Tao Guo. Diagnosis and management of intramural ectopic pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 974-979.
[14] Ovadya Rosenbluh, Asnat Walfisch. Birth defects associated with obesity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 472-477.
[15] Sara Oday, Maysoon Sharief. The role of salivary progesterone and cervical length measurement in predicting risk of spontaneous preterm birth[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 509-513.
No Suggested Reading articles found!